High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Montserrat Lonca EfaVIP Cohort Study Group Federico Pulido Miguel Torralba Felipe García Jose R. Arribas Josep Maria Gatell |
| Publication date | July 1, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |